A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis (DreaMS) ClinicalTrials.gov, 3 Feb 2012 Accessed on 20 Feb 2012 from http://clinicaltrials.gov/ct2/show/NCT01081782. CommentRecommendBookmarkWatch